Potential Effects on Elderly People From Nirsevimab Use in Infants
Nirsevimab therapy has the potential to revolutionize infant respiratory syncytial virus (RSV) prophylaxis. But other populations suffering RSV, such the elderly or those over 60, may also be protected by using this novel antibody in the infant group. It is true that some studies link the use of nir...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-04-01
|
| Serier: | Open Respiratory Archives |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2659663624000237 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|